[ Price : $8.95]
FDA releases a form FDA-483 with six observations from an inspection at Indias Global Calcium active pharmaceutical ingredient man...[ Price : $8.95]
Consumers for Dental Choice and two other advocacy groups again petition FDA to ban the use of mercury amalgams in dentistry, espe...[ Price : $8.95]
FDA approves a Regeneron Pharmaceuticals BLA for Otarmeni (lunsotogene parvec-cwha), the first gene therapy for a form of inherite...[ Price : $8.95]
FDA commissioner Marty Makary says the agency is not planning to eliminate direct-to-consumer pharmaceutical advertising, even as ...[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially dangerous defect in certain angiographic syringes inclu...[ Price : $8.95]
FDA and CMS unveil a new joint initiative aimed at significantly shortening the time it takes for innovative medical devices to re...[ Price : $8.95]
FDA sends Grace Therapeutics a complete response letter rejecting approval for its experimental treatment GTx-104 (nimodipine), ci...[ Price : $8.95]
A Clinical Trial Vanguard column demonstrates how synthetic biology is outstripping FDAs regulatory framework under the Supreme Co...